Ropes & Gray

United States


Practice area

IFLR1000 Reviews

Financial and corporate

Ropes & Gray stands out for its M&A, private equity, hedge funds, private equity funds, registered funds and financial services regulatory practices. The firm also has strengths in banking, debt capital markets, equity capital markets and restructuring and insolvency.  

The capital markets group advised issuers and underwriters on a range of IPOs and secondary offerings over the research period. Many of these equity capital markets deals involved the pharmaceutical sector.  

The M&A practice led significant deals in the pharmaceutical, retail and food and beverage industries over the research period.  

Recent Deal Data highlights 

•Avrobio NASADQ IPO 

•Biogen $877 million acquisition of Nightstar Therapeutics  

•Cambrex $425 million acquisition of Halo Pharma  

•CCMP Capital Advisors $1 billion acquisition of BGIS 

•Elanco Animal Health NYSE IPO 

•Genstar Capital/Bracket Capital $1 billion acquisition of CRH Health 

•Greif $1.8 billion acquisition of Caraustar Industries 

•Hillenbrand $2 billion acquisition of Milacron